Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing-Jie Liang

Showing results (1-10 of 413) with videos related to

Pageof 42
Sort By:
Current Drug Delivery|January 24, 2020
PrefaceXing-Jie Liang
Current Drug Delivery|December 8, 2018
PrefaceXing-Jie Liang
Biotechnology Advances|June 11, 2014
Nanotechnology and cancer nanomedicineXing-Jie Liang
Theranostics|March 27, 2012
Nano-carbons as theranosticsZhuang Liu, Xing-Jie Liang
Science China. Life Sciences|April 21, 2018
Nanobiotechnology and nanomedicine: small change brings big differenceShizhu Chen, Xing-Jie Liang
Chinese Journal of Cancer|January 13, 2012
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnologyXue Xue, Xing-Jie Liang
Accounts of Chemical Research|July 8, 2011
Theranostic nanoparticles engineered for clinic and pharmaceuticsXiaowei Ma, Yuliang Zhao, Xing-Jie Liang
Progress in Biomedical Engineering (Bristol, England)|December 17, 2024
Biomedical applications of the engineered AIEgen-lipid nanostructure<i>in vitro</i>and<i>in vivo</i>Meng Suo, Tianfu Zhang, Xing-Jie Liang
Biotechnology Journal|September 18, 2018
Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid ArthritisLu Liu, Weisheng Guo, Xing-Jie Liang
Pharmaceutics|February 26, 2025
Extracellular Vesicle-Based Strategies for Tumor ImmunotherapyLuksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
Pageof 42

Showing results (1-10 of 413) with videos related to

Sort By:
Pageof 42
Current Drug Delivery|January 24, 2020
PrefaceXing-Jie Liang
Current Drug Delivery|December 8, 2018
PrefaceXing-Jie Liang
Biotechnology Advances|June 11, 2014
Nanotechnology and cancer nanomedicineXing-Jie Liang
Theranostics|March 27, 2012
Nano-carbons as theranosticsZhuang Liu, Xing-Jie Liang
Science China. Life Sciences|April 21, 2018
Nanobiotechnology and nanomedicine: small change brings big differenceShizhu Chen, Xing-Jie Liang
Chinese Journal of Cancer|January 13, 2012
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnologyXue Xue, Xing-Jie Liang
Accounts of Chemical Research|July 8, 2011
Theranostic nanoparticles engineered for clinic and pharmaceuticsXiaowei Ma, Yuliang Zhao, Xing-Jie Liang
Progress in Biomedical Engineering (Bristol, England)|December 17, 2024
Biomedical applications of the engineered AIEgen-lipid nanostructure<i>in vitro</i>and<i>in vivo</i>Meng Suo, Tianfu Zhang, Xing-Jie Liang
Biotechnology Journal|September 18, 2018
Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid ArthritisLu Liu, Weisheng Guo, Xing-Jie Liang
Pharmaceutics|February 26, 2025
Extracellular Vesicle-Based Strategies for Tumor ImmunotherapyLuksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
Pageof 42